0001179110-12-012652.txt : 20120809 0001179110-12-012652.hdr.sgml : 20120809 20120809190040 ACCESSION NUMBER: 0001179110-12-012652 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120807 FILED AS OF DATE: 20120809 DATE AS OF CHANGE: 20120809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aguiar Michael W CENTRAL INDEX KEY: 0001318005 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 121022012 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4 1 edgar.xml FORM 4 - X0306 4 2012-08-07 0 0001080014 THERAVANCE INC THRX 0001318005 Aguiar Michael W THERAVANCE, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Sr VP, Chief Financial Officer Common Stock 2012-08-07 4 M 0 60000 16.25 A 217924 D Common Stock 2012-08-07 4 S 0 60000 27.04 D 157924 D Stock Option (Right to Buy) 16.25 2012-08-07 4 M 0 60000 0 D 2018-07-22 Common Stock 60000 0 D Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c). This transaction was executed in multiple trades at prices ranging from $26.60 to $27.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Immediately exercisable. Michael W. Aguiar 2012-08-09